日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia

慢性淋巴细胞白血病中克隆性造血的格局和演变

Al-Sawaf, Othman; Locher, Benjamin N; Christen, Friederike; Hablesreiter, Raphael; Rajamani, Anantharamanan; Robrecht, Sandra; Zhang, Can; Fink, Anna Maria; Tausch, Eugen; Schneider, Christof; Ritgen, Matthias; Kreuzer, Karl-Anton; Kopp, Klara; Mertz, Marie-Elisa; Fustero-Torre, Coral; Kleo, Karsten; Seymour, John; Blombery, Piers; Bullinger, Lars; Chyla, Brenda; Jin, Hyun Yong; Jiang, Yanwen; Stilgenbauer, Stephan; Hallek, Michael; Eichhorst, Barbara; Langerbeins, Petra; Fischer, Kirsten; Damm, Frederik

Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets

通过分析汇总的临床数据集来改进DDX41变异体的分类

Tiong, Ing Soo; Hunter, Sally; Kankanige, Yamuna; Mehta, Nikita N; Chisholm, Ryan A; Wu, Simon; Li, Jamilla; Casan, Joshua; Chan, Kah Lok; Godley, Lucy A; Fox, Lucy C; Blombery, Piers

T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft function

T细胞和单核细胞活化与造血干细胞相互作用共同塑造了移植后移植物功能不良时的免疫微环境。

Prabahran, Ashvind; Wu, Zhijie; Gao, Shouguo; Morgan, Huw; Holzwart, Nicholas; Ludford-Menting, Mandy; Rawicki, Mayani; Klass, Jessica; Koo, Ray-Mun; Wilson, Clarissa; Blombery, Piers; Tan, Chin Wee; Indukuri, Saanvi; Chee, Lynette; Ritchie, David; Young, Neal S; Feng, Xingmin; Koldej, Rachel

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者停药后疾病进展,可使用维奈托克和利妥昔单抗进行再治疗

Brander, Danielle M; Roberts, Andrew W; Kipps, Thomas J; Ma, Shuo; Anderson, Mary Ann; Boyer, Michelle; Blombery, Piers; Popovic, Relja; Roser, Jordan; Liu, Zhuangzhuang; Chyla, Brenda; Seymour, John F

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice

慢性淋巴细胞白血病靶向治疗耐药性:现状及临床和诊断实践展望

Blombery, Piers; Chatzikonstantinou, Thomas; Gerousi, Marina; Rosenquist, Richard; Gaidano, Gianluca; Pospisilova, Sarka; Roberts, Andrew W; Birkinshaw, Richard W; Rossi, Davide; Scarfo, Lydia; Seymour, John F; Stilgenbauer, Stephan; Wiestner, Adrian; Woyach, Jennifer A; Brown, Jennifer R; Ghia, Paolo; Stamatopoulos, Kostas

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer

乳腺癌患者接受维奈托克治疗后出现BAX突变克隆性造血

Tiong, Ing S; Nguyen, Tamia; Chua, Chong C; Teh, Charis E; Muttiah, Christine; Ftouni, Sarah; Seymour, John F; Gray, Daniel; Roberts, Andrew W; Dawson, Sarah-Jane; Lindeman, Geoffrey J; Blombery, Piers

Using artificial intelligence (AI) to model clinical variant reporting for next generation sequencing (NGS) oncology assays

利用人工智能(AI)对下一代测序(NGS)肿瘤检测的临床变异报告进行建模

Doig, Kenneth D; Perera, Rashindrie; Kankanige, Yamuna; Fellowes, Andrew; Li, Jason; Lupat, Richard; Thompson, Ella R; Blombery, Piers; Fox, Stephen B

Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma

循环肿瘤DNA是血管免疫母细胞性T细胞淋巴瘤疗效的生物标志物

Yannakou, Costas Kleanthes; Wu, Simon; Rajah, Karthik; Abeyakoon, Chathuri; Nguyen-Ngo, Caitlyn; Yap, Yan Zhuang; Sheldon, James; Blombery, Piers; Prince, Henry Miles

Closing the gap between biology and classification in splenic B-cell lymphomas

弥合脾脏B细胞淋巴瘤生物学与分类之间的差距

Blombery, Piers; de Jong, Daphne; Ferry, Judith A; Hsi, Eric D; Ondrejka, Sarah L; Seymour, John F; Zamò, Alberto; Tzankov, Alexandar

Heterozygous germline TET2 loss-of-function variants associated with an ALPS-like phenotype

与ALPS样表型相关的杂合种系TET2功能缺失变异

Harrop, Sean; Casan, Joshua; Rose, Hannah; Sullivan, Michael; Mehr, Sam; Ngu, Henry; Caldwell, Imogen; McKendrick, Joseph; Anderson, Mary Ann; Den Elzen, Nicole; Goode, Erin; Fox, Lucy C; Lade, Stephen; Blombery, Piers